Swedish immunoassay and peptide synthesis firm Gyros Protein Technologies has been acquired by Mesa Laboratories in a deal worth $180 million (€163 million). Colorado-based quality control instruments and consumables firm Mesa Laboratories says it is increasing its presence in the discovery, development and manufacturing of biotherapeutics through the acquisition, adding Gyros’ immunoassay platform. “We completed a business combination (the “GPT Acquisition”) whereby we acquired the common stock of Gyros Protein Technologies Holding AB (“GPT”), a company whose business provides Immunoassay…
Monday, November 11, 2019 Daily Archives
Aspen alert! Novartis buys assets for $330m in Japan boost
Novartis division Sandoz has acquired the Japanese business of Aspen Global Incorporated (AGI), bolstering its biosimilar and generics presence in the region. South African pharma firm Aspen Holdings opened the Japanese subsidiary Aspen Japan K.K. in May 2015, with an aim bring its oncology, immunosuppressant, anti-inflammatory, hypertension, and anticoagulant products to the market. Today, Sandoz, the generics and biosimilar division of Swiss Biopharma firm Novartis, has announced it will pay an initial €300 million ($330 million) to buy shares in…